Old Web
English
Sign In
Acemap
>
Paper
>
Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
2021
Massimo Iavarone
Federica Invernizzi
T. Ivanics
Stefano Mazza
Claudio Zavaglia
Marco Sanduzzi Zamparelli
M Fraile López
C Czauderna
G.G. Di Costanzo
Sherrie Bhoori
Matthias Pinter
Matteo Angelo Manini
Giuliana Amaddeo
A. Fernández Yunquera
Federico Piñero
M.J. Blanco Rodríguez
Maria Margarita Anders
G. Aballay Soteras
Gerda Elisabeth Villadsen
P. Daechul Yoon
Lucia Cesarini
Álvaro Díaz-González
M.L. González-Diéguez
Raffaella Tortora
Arndt Weinmann
Vincenzo Mazzaferro
M. Romero Cristóbal
Gonzalo Crespo
Hélène Regnault
M. De Giorgio
M. Varela
R Prince
L. Scuddeler
Maria Francesca Donato
Marcus-Alexander Wörns
Jordi Bruix
G. Sapisochin
Pietro Lampertico
M. Reig
Keywords:
Regorafenib
Medicine
Sorafenib
Oncology
Liver transplantation
Internal medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]